Tag: ESMO,IASLC,In the News,NSCLC,Non-Small Cell Lung Cancer,biomarker,blood-based cancer test,cancer diagnostics,liquid biopsy,oncology,personalized Medicine Coalition

The Personalized Medicine Coalition (PMC) applauds the substantial number of new studies focusing on targeted approaches to the treatment of lung cancer presented at the second joint European Lung Cancer Conference of the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO) in Geneva.